Analyst Ratings For NASDAQ:CKPT – Checkpoint Therapeutics (NASDAQ:CKPT)
Today, HC Wainwright reiterated its Buy rating on NASDAQ:CKPT – Checkpoint Therapeutics (NASDAQ:CKPT) with a price target of $11.00.
Some recent analyst ratings include
- 5/11/2018-HC Wainwright Reiterated Rating of Buy.
- 3/22/2017-Ladenburg Thalmann initiated coverage with a Buy rating.
Recent Insider Trading Activity For NASDAQ:CKPT – Checkpoint Therapeutics (NASDAQ:CKPT)
NASDAQ:CKPT – Checkpoint Therapeutics (NASDAQ:CKPT) has insider ownership of 8.70% and institutional ownership of 0.56%.
Recent Trading Activity for NASDAQ:CKPT – Checkpoint Therapeutics (NASDAQ:CKPT)
Shares of NASDAQ:CKPT – Checkpoint Therapeutics closed the previous trading session at with 3.490000009536743 shares trading hands.